Literature DB >> 26095424

Polydatin: a new therapeutic agent against multiorgan dysfunction.

Zhenhua Zeng1, Zhongqing Chen1, Tao Li2, Junli Zhang2, Youguang Gao3, Siqi Xu4, Shumin Cai2, Ke-seng Zhao5.   

Abstract

BACKGROUND: Polydatin (PD), a monocrystalline and polyphenolic drug isolated from a traditional Chinese herb (Polygonum cuspidatum), is protective against mitochondrial dysfunction and has been approved for clinical trials in the treatment of shock. However, whether the administration of PD has a therapeutic effect on multiple-organ dysfunction syndrome (MODS) requires investigation.
MATERIAL AND METHODS: MODS was induced in Sprague-Dawley rats via hemorrhage and ligation and puncture of cecum-induced sepsis. The rats were divided into three groups as follows: MODS + PD, MODS + normal saline, and a control group (no treatment). Survival time, blood biochemical indexes, and histopathologic changes in various organs were evaluated; serum oxidative stress (advanced oxidative protein products [AOPPs]) and proinflammatory cytokines (tumor necrosis factor-α, interleukin 1β, and interleukin 6) were assayed using enzyme-linked immunosorbent assay. Apoptosis-related protein expression (B-cell lymphoma-2 [Bcl-2] and Bax) was assayed by immunohistochemical and Western blotting methods, whereas caspase-3 activity was assayed by spectrophotometry.
RESULTS: PD improved organ function, prolonged survival time, and reduced MODS incidence and serum levels of AOPPs and proinflammatory cytokines. It also decreased Bax levels and caspase-3 activity and increased Bcl-2 levels in the kidney and liver.
CONCLUSIONS: PD may serve as a potential therapeutic for MODS, as it suppresses oxidative stress, inhibits inflammatory response, attenuates apoptosis, and protects against mitochondrial dysfunction.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Inflammation; Multiorgan dysfunction syndrome; Oxidative stress; Polydatin

Mesh:

Substances:

Year:  2015        PMID: 26095424     DOI: 10.1016/j.jss.2015.05.041

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  8 in total

1.  Continuous blood purification ameliorates clinical signs and corrects the plasma phospholipid levels of patients with multiple organ dysfunction syndromes.

Authors:  Wei Wen; Kun Wang; Zhi-Ming Jiang; Zhong-Hui Zhang; Lei Zhou
Journal:  J Clin Lab Anal       Date:  2018-02-18       Impact factor: 2.352

2.  Neuroprotective effects of polydatin against mitochondrial-dependent apoptosis in the rat cerebral cortex following ischemia/reperfusion injury.

Authors:  Youguang Gao; Ting Chen; Xianghui Lei; Yunfeng Li; Xingui Dai; Yuanyuan Cao; Qionglei Ding; Xiabao Lei; Tao Li; Xianzhong Lin
Journal:  Mol Med Rep       Date:  2016-11-11       Impact factor: 2.952

3.  Polydatin Protects Rat Liver against Ethanol-Induced Injury: Involvement of CYP2E1/ROS/Nrf2 and TLR4/NF-κB p65 Pathway.

Authors:  Qiong-Hui Huang; Lie-Qiang Xu; Yu-Hong Liu; Jia-Zhen Wu; Xue Wu; Xiao-Ping Lai; Yu-Cui Li; Zi-Ren Su; Jian-Nan Chen; You-Liang Xie
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-08       Impact factor: 2.629

4.  Role of Parkin-mediated mitophagy in the protective effect of polydatin in sepsis-induced acute kidney injury.

Authors:  Youguang Gao; Xingui Dai; Yunfeng Li; Guicheng Li; Xianzhong Lin; Chenmu Ai; Yuanyuan Cao; Tao Li; Bo Lin
Journal:  J Transl Med       Date:  2020-03-04       Impact factor: 5.531

5.  SIRT1 attenuates sepsis-induced acute kidney injury via Beclin1 deacetylation-mediated autophagy activation.

Authors:  Zhiya Deng; Maomao Sun; Jie Wu; Haihong Fang; Shumin Cai; Sheng An; Qiaobing Huang; Zhenfeng Chen; Chenglun Wu; Ziwei Zhou; Haoran Hu; Zhenhua Zeng
Journal:  Cell Death Dis       Date:  2021-02-26       Impact factor: 8.469

Review 6.  Polydatin: A Critical Promising Natural Agent for Liver Protection via Antioxidative Stress.

Authors:  Dandan Tang; Qing Zhang; Huxinyue Duan; Xun Ye; Jia Liu; Wei Peng; Chunjie Wu
Journal:  Oxid Med Cell Longev       Date:  2022-02-10       Impact factor: 6.543

Review 7.  Polydatin: Pharmacological Mechanisms, Therapeutic Targets, Biological Activities, and Health Benefits.

Authors:  Ahmad Karami; Sajad Fakhri; Leila Kooshki; Haroon Khan
Journal:  Molecules       Date:  2022-10-01       Impact factor: 4.927

8.  Polydatin Attenuates H2O2-Induced Oxidative Stress via PKC Pathway.

Authors:  Huilian Qiao; Hao Chen; Yuhang Dong; He Ma; Guangchao Zhao; Fakuan Tang; Zhen Li
Journal:  Oxid Med Cell Longev       Date:  2016-01-04       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.